ProJect Pharmaceutics Expands Facilities for Formulation and Lyophilization Process Development to Meet Safety Requirements for GMO S2 and BSL-2 Biological Products

Wednesday, February 28, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

ProJect Pharmaceutics (PJP), specialized in formulation and process development for parenteral drug products, announces that it has extended its safety facilities by laboratories dedicated to handle GMO S2 and BSL-2 based biological products such as live virus vaccines, protective and therapeutic vaccines, as well as gene and cell therapy products.

Live Virus Vaccines


The GMO S2 and BSL-2 safety lab is equipped with a dedicated pilot freeze dryer to design tailored lyophilization cycles both maximally robust and efficient. Cutting-edge analytical high-throughput methods have also been implemented in order to select the most effective combination of excipients for the final drug product to maintain the active quaternary structure of a virus capsid and avoiding aggregation, even under stress conditions like elevated temperature, freezing and freeze drying.

The company’s long lasting experience and deep understanding of the challenges when processing bio-therapeutics enables PJP to provide smart formulations and manufacturing processes for virus vaccines or other classified drug products in their dedicated labs that fulfil the mandatory safety requirements up to GMO S2 and BSL-2 classification. Customers will benefit from safer products with an optimized stability profile and reduced manufacturing costs.
Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store